Inclusive design is often reduced to accessibility and compliance. Yet in an age of AI-mediated systems, design determines whether citizens retain agency or are silently processed. Inclusion is no longer ethical decoration — it is Europe’s social infrastructure.
Health & Wellbeing
How technology, policy and society shape the future of health, resilience and human wellbeing.
The MedTech landscape in 2026 is defined not just by innovation, but by how technology earns trust. As AI, robotics and data-driven care accelerate, the real differentiator is no longer what technology can do — but how human it feels. The Big Five—Philips, GE HealthCare, Medtronic, J&J MedTech and Siemens Healthineers—each navigate this tension differently.
Healthcare is becoming increasingly electronic. From wearable sensors and smart patches to remote diagnostics and continuous monitoring, digital technologies now sit directly on the human body — sometimes even inside it. These innovations promise earlier detection, better outcomes and more personalised care. Yet beneath this progress lies a growing contradiction.
In the world of medical technology, five giants dominate the landscape: Philips, Siemens Healthineers, GE HealthCare, Medtronic and Johnson & Johnson MedTech. They shape hospitals, diagnostic labs and operating rooms worldwide. But their influence goes far beyond machines and software: their story is one of technological innovation intertwined with human care, navigating governance challenges, mergers and ethically complex healthcare decisions.
In a global technology landscape dominated by speed, scale and spectacle, Philips is pursuing a different ambition. Not to reclaim market leadership in the traditional sense, but to redefine what leadership in medical technology means in the first place.
In traditional finance, success is measured almost exclusively by profits, revenue growth and shareholder returns. But what if the metrics of value shifted from mere financial performance to human-centered outcomes — wellbeing, sustainability and trust? The concept of “empathy as capital” challenges conventional thinking, proposing that companies which prioritize societal good alongside profit may be the most resilient and innovative in the long term.
